Friday, May 12, 2017 10:19:50 AM
And an even simpler question is ..... Why didn't they just use available cash to buy back the Advent shares?
With $7mil due soon, big milestone payments in 2018, and Novartis paying for half Ph2 and 100% of Ph3 for emricisan AND the fact they have $80mil in cash on hand right now.....why why why?
I still like the company and stock for the rest of the year and beyond but this does knock Mentos down a few notches in my book.
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM